Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The preparation of this study was supported in part by NIH/NCI Cancer Center Support Grant P30 CA008748 to Memorial Sloan Kettering Cancer Center, and this study was presented in poster format at the 44th Annual San Antonio Breast Cancer Symposium, 7–10 December 2021, San Antonio, TX. Dr. Babak Mehrara reports receipt of an investigator-initiated grant from Pfizer, Regeneron, and Puretech, receipt of royalty payments from Puretech, and an advisory position with Mediflix. Dr. Andrea L. Pusic is a codeveloper of the BREAST-Q and receives totalities when it is used in for-profit, industry-sponsored clinical trials. All other authors have no conflict of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Audree B. Tadros: Shared first authorship.
Rights and permissions
About this article
Cite this article
Chu, J.J., Tadros, A.B., Gallo, L. et al. ASO Visual Abstract: Interpreting the BREAST-Q for Breast-Conserving Therapy—Minimal Important Differences and Clinical Reference Values. Ann Surg Oncol 30, 4085–4086 (2023). https://doi.org/10.1245/s10434-023-13326-5
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-13326-5